Acura Pharmaceuticals, Inc. Announces Issuance of U.S. Patent for Deterring Abuse of Opioid Containing Dosage Forms
April 16, 2007 16:01 ET
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., April 16, 2007 (PRIME NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced receipt from the United States Patent and Trademark Office (the "USPTO") of U.S. Patent No....
Acura Pharmaceuticals, Inc. Secures Bridge Funding
April 02, 2007 16:01 ET
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., April 2, 2007 (PRIME NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has secured gross proceeds of $600,000 and a commitment for additional funding of up to...
Acura Pharmaceuticals, Inc. Reports 2006 Financial Results and Cash Reserves
March 15, 2007 16:01 ET
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., March 15, 2007 (PRIME NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced a net loss of $6.0 million or $0.08 per common share for calendar year 2006 compared to a...
Acura Pharmaceuticals, Inc. Updates OxyADF Tablets Development Program and Results of Study AP-ADF-102
March 15, 2007 16:01 ET
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., March 15, 2007 (PRIME NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced results of Study AP-ADF-102 ("Study 102"), a phase II clinical trial for OxyADF (oxycodone...
Acura Pharmaceuticals, Inc. Completes Draw Down of November, 2006 Bridge Funding Commitment
February 20, 2007 16:01 ET
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., Feb. 20, 2007 (PRIME NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has completed the draw down of the $2.0 million November, 2006 bridge funding commitment...
Acura Pharmaceuticals, Inc. Announces Notice of Allowance for Issuance of Patent for Deterring Abuse of Opioid Containing Dosage Forms
December 11, 2006 16:01 ET
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., Dec. 11, 2006 (PRIME NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR), today announced receipt from the United States Patent and Trademark Office of a Notice of Allowance for a...
Acura Pharmaceuticals, Inc. Secures Bridge Funding
November 30, 2006 17:44 ET
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., Nov. 30, 2006 (PRIME NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has secured gross proceeds of $534,000 and a commitment for additional funding of up to...
Acura Pharmaceuticals, Inc. Announces 3rd Quarter 2006 Financial Results and Cash Reserves Update
November 03, 2006 17:00 ET
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., Nov. 3, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced a net loss of $3.1 million or $0.01 per share for the quarter ending September 30, 2006 compared to...
Acura Pharmaceuticals, Inc. Secures Bridge Funding
October 20, 2006 16:01 ET
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., Oct. 20, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has secured gross proceeds of $620,000 under a term loan agreement (the "Loan") with Essex...
Acura Pharmaceuticals, Inc. Secures Bridge Funding
September 22, 2006 16:10 ET
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., Sept. 22, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has secured gross proceeds of $489,000 under a term loan agreement (the "Loan") with Essex...